Novoheart Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Novoheart is a biotechnology research company based in Boston, Massachusetts, operating as a wholly owned subsidiary of Medera. It focuses on disease modeling and drug discovery using its mini-heart technology to create bioengineered human heart constructs. The product lineup includes a bioengineered miniature human heart model used to assess drug toxicity and efficacy in human tissues. The company serves researchers and pharmaceutical developers seeking human-relevant cardiac models to study diseases and screen therapies, reducing reliance on animal studies. In 2025, Novoheart announced a collaboration with the University of California San Diego School of Medicine and Mayo Clinic to advance mini-heart models for hypoplastic left heart syndrome.